Hongyi Hu1, Dongsheng Shi1, Chenlu Hu2, Xiao Yuan3, Juan Zhang1, Huaqin Sun1. 1. Department of Anesthesiology, Zhejiang Provincial Hospital of TCMHangzhou 310006, Zhejiang, China. 2. Department of General Surgery, The Second Affiliated Hospital Zhejiang University School of MedicineZhejiang, China. 3. Department of Endocrinology, Zhejiang Provincial Hospital of TCMHangzhou 310006, Zhejiang, China.
Abstract
OBJECTIVE: RAGE pathway plays crucial effects in causing acute lung injury (ALI). Dexmedetomidine (DEX) is showed to mitigate sepsis-stimulated ALI. However, its mechanisms have not been verified. The study was to evaluate whether the RAGE pathway participated in the actions of DEX on sepsis-stimulated ALI in rats. METHODS: Male rats were administrated with intravenously DEX 30 min after sepsis. At 24 h of sepsis, lung myeloperoxidase (MPO) and macrophages in the bronchoalveolarlavage fluid (BALF) were observed. The actions of DEX on pro-inflammatory molecules and related mechanisms were determined by immunological methods. RESULTS: It was indicated that DEX markedly attenuated CLP-stimulated augment of lung inflammatory cells infiltration, along with significantly mitigated MPO activity. Besides, DEX obviously reduced lung wet/dry weight ratio and the levels of HMGB1 and RAGE in BALF and lung tissue. Moreover, DEX post-treatment apparently attenuated the histopathological lung injury compared with CLP model group. Furthermore, western blot analysis revealed that DEX efficiently restrained the activation of IκB-α, NF-κB p65, and MAPK. CONCLUSION: Our studies demonstrated that DEX attenuates the aggravation of sepsis-stimulated ALI via down regulation of RAGE pathway, which has a potential value in the clinical therapy.
OBJECTIVE:RAGE pathway plays crucial effects in causing acute lung injury (ALI). Dexmedetomidine (DEX) is showed to mitigate sepsis-stimulated ALI. However, its mechanisms have not been verified. The study was to evaluate whether the RAGE pathway participated in the actions of DEX on sepsis-stimulated ALI in rats. METHODS: Male rats were administrated with intravenously DEX 30 min after sepsis. At 24 h of sepsis, lung myeloperoxidase (MPO) and macrophages in the bronchoalveolarlavage fluid (BALF) were observed. The actions of DEX on pro-inflammatory molecules and related mechanisms were determined by immunological methods. RESULTS: It was indicated that DEX markedly attenuated CLP-stimulated augment of lung inflammatory cells infiltration, along with significantly mitigated MPO activity. Besides, DEX obviously reduced lung wet/dry weight ratio and the levels of HMGB1 and RAGE in BALF and lung tissue. Moreover, DEX post-treatment apparently attenuated the histopathological lung injury compared with CLP model group. Furthermore, western blot analysis revealed that DEX efficiently restrained the activation of IκB-α, NF-κB p65, and MAPK. CONCLUSION: Our studies demonstrated that DEX attenuates the aggravation of sepsis-stimulated ALI via down regulation of RAGE pathway, which has a potential value in the clinical therapy.
Authors: Eirini Christaki; Steven M Opal; James C Keith; Nubar Kessimian; John E Palardy; Nicolas A Parejo; Xiang Yang Tan; Nicole Piche-Nicholas; Lioudmila Tchistiakova; George P Vlasuk; Kathleen M Shields; Jeffrey L Feldman; Edward R Lavallie; Maya Arai; William Mounts; Debra D Pittman Journal: Shock Date: 2011-05 Impact factor: 3.454
Authors: Rongqian Wu; Weifeng Dong; Mian Zhou; Fangming Zhang; Corrado P Marini; Thanjavur S Ravikumar; Ping Wang Journal: Am J Respir Crit Care Med Date: 2007-07-12 Impact factor: 21.405